Hongkun Bao

Dr. Hongkun Bao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HBHongkun Bao
Hongkun Bao
HLHaoran Li
Haoran Li
YJYue Jia
Yue Jia
YXYuhuan Xiao
Yuhuan Xiao
SLShaolei Luo
Shaolei Luo
JDJing Du
Jing Du

1 June 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
HLHaoran Li
Haoran Li
YXYuhuan Xiao
Yuhuan Xiao
LHLi Han
Li Han
YJYue Jia
Yue Jia
SLShaolei Luo
Shaolei Luo
HBHongkun Bao
Hongkun Bao

5 April 2021 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
YJYue Jia
Yue Jia
DZDandan Zhang
Dandan Zhang
HYHua Yin
Hua Yin
HLHaoran Li
Haoran Li
JDJing Du
Jing Du
HBHongkun Bao
Hongkun Bao
Neuroinflammation plays an important role in the onset and progression of neurodegenerative diseases. Microglia-mediated neuroinflammation have been proved to be the main reason for causing the neurodegenerative diseases. Ganoderic acid A (GAA), isolated from Ganoderma lucidum, showed anti-inflammatory effect in metabolism diseases. However, little research has been focused on the effect of GAA in neuroinflammation and the related mechanism. In the present study, lipopolysaccharide(LPS)-stimulated BV2 microglial cells were used to evaluate the anti-inflammatory capacity of GAA. Our data showed that GAA significantly suppressed LPS-induced BV2 microglial cells proliferation and activation in vitro. More strikingly, GAA promoted the conversion of BV2 microglial cells from M1 status induced by LPS to M2 status. Furthermore, GAA inhibited the pro-inflammatory cytokines release and promoted neurotrophic factor BDNF expression in LPS-induced BV2 microglial cells. Finally, we found that the expression of farnesoid-X-receptor (FXR) was prominently downregulated in LPS-stimulated BV2 microglial cells, antagonism of FXR with z-gugglesterone and FXR siRNA can reverse the effect of GAA in LPS-induced BV2 microglial cells. Taking together, our findings demonstrate that GAA can significantly inhibit LPS-induced neuroinflammation in BV2 microglial cells via activating FXR receptor.

1 March 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
YJYue Jia
Yue Jia
DZDandan Zhang
Dandan Zhang
HLHaoran Li
Haoran Li
SLShaolei Luo
Shaolei Luo
YXYuhuan Xiao
Yuhuan Xiao
HBHongkun Bao
Hongkun Bao

11 November 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
XSXingzong Sun
Xingzong Sun
MQMenghan Qian
Menghan Qian
HLHongliang Li
Hongliang Li
LWLei Wang
Lei Wang
YZYunjie Zhao
Yunjie Zhao
HBHongkun Bao
Hongkun Bao
Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS) that is characterized by myelin damage, followed by axonal and ultimately neuronal loss, which has been found to be associated with mitophagy. The etiology and pathology of MS remain elusive. However, the role of FK506 binding protein 5 (FKBP5, also called FKBP51), a newly identified gene associated with MS, in the progression of the disease has not been well defined. Here, we observed that the progress of myelin loss and regeneration in Fkbp5ko mice treated with demyelination for the same amount of time was significantly slower than that in wild-type mice, and that mitophagy plays an important regulatory role in this process. To investigate the mechanism, we discovered that the levels of FKBP5 protein were greatly enhanced in the CNS of cuprizone (CPZ) mice and the myelin-denuded environment stimulates significant activation of the PINK1/Parkin-mediated mitophagy, in which the important regulator, PPAR-γ, is critically regulated by FKBP5. This study reveals the role of FKBP5 in regulating a dynamic pathway of natural restorative regulation of mitophagy through PPAR-γ in pathological demyelinating settings, which may provide potential targets for the treatment of demyelinating diseases.

28 December 2022 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
DZDandan Zhang
Dandan Zhang
YJYue Jia
Yue Jia
XSXingzong Sun
Xingzong Sun
HLHaoran Li
Haoran Li
MYMin Yin
Min Yin
HBHongkun Bao
Hongkun Bao
Demyelinating diseases such as multiple sclerosis (MS) are chronic inflammatory autoimmune diseases and involve demyelination and axonal degeneration. Microglia rapidly respond to changes in the environment by altering morphotype and function during the progressive disease stage. Although substantial progress has been made in the drug development for MS, treatment of the progressive forms of the disease remains unsatisfactory. There is great interest in identifying novel agents for treating MS. Lentinus edodes is a traditional food, which can improve physiological function. Lentinan (LNT), a type of polysaccharide extracted from mushroom Lentinus edodes, is an anti-inflammatory and immunomodulatory agent. Here, we studied the remyelination effects of LNT and its therapeutic target in regulating the functions of neuroinflammation. We found that LNT enhanced remyelination and rescued motor deficiency by regulating dectin-1 receptor to inhibit neuroinflammation and microglial cell transformation. LNT promoted the conversion of microglial cells from the M1 status induced by LPS to the M2 status, enhanced the anti-inflammatory markers IL-10 and BDNF, inhibited inflammatory markers TNF-α and IL-1β, and downregulated the microglia activation and oligodendrocyte and astrocyte proliferation by modulating dectin-1. If we injected the dectin-1-specific inhibitor laminarin (Lam), the remyelination effects induced by LNT were completely abolished. Thus, these results suggest that LNT is a novel and potential therapeutic agent that can rescue MS neuroimmune imbalance and remyelination through a dectin-1 receptor-dependent mechanism.